BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2019 ,inter alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2019. Further, pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, the trading window for dealing in shares of the Company was closed for all the Designated Persons and their immediate relatives of the Company from July 01, 2019 and shall remain closed till 48 hours after the announcement of the Financial Results i.e. up to Wednesday, August 14, 2019. Kindly acknowledge and take on record the same.
Source : BSE - www.bseindia.com
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.